Dr. Reddy's Zytorvi Secures DCGI Approval for Advanced Esophageal Cancer Treatment
Dr. Reddy's Laboratories receives DCGI approval for Zytorvi for advanced esophageal cancer treatment in India. The drug reduced death risk by 42% in trials.
Wednesday, 21 October 2026
NSE & BSE filings, as they land
ALFA News
Straight from the exchange filing